Profund Advisors’s Antares Pharma, Inc. ATRS Stock Holding History

Profund Advisors’s Portfolio ATRS Stock Details ATRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-15,247	Closed	-$63K	–	1349
2022 Q1	$63K	Sell	15,247 -1,066	-7%	-$3.87K	﹤0.01%	1336
2021 Q4	$58K	Buy	16,313 +663	+4%	+$2.32K	﹤0.01%	1360
2021 Q3	$57K	Sell	15,650 -650	-4%	-$2.63K	﹤0.01%	1339
2021 Q2	$72K	Buy	+16,300	New	+$66.4K	﹤0.01%	1412
2014 Q3	–	Sell	-12,765	Closed	-$34K	–	1477
2014 Q2	$34K	Buy	12,765 +765	+6%	+$2.3K	﹤0.01%	1550
2014 Q1	$42K	Buy	+12,000	New	+$53.2K	﹤0.01%	1578

Other funds holding ATRS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Profund Advisors's ATRS Position: Q2 2022 in Review

Profund Advisors sold out of Antares Pharma, Inc. (ATRS) in Q2 2022, closing a stake of 15,247 shares — an estimated $63K sold.

Profund Advisors first reported a position in ATRS in Q1 2014 and held it in 6 quarters. The position peaked at $72K in Q2 2021. 1 fund tracked by Wall St. Rank holds ATRS as of Q2 2022.

Profund Advisors reported no remaining Antares Pharma, Inc. position as of Q2 2022 after selling out during the quarter.
Profund Advisors sold 15,247 Antares Pharma, Inc. shares in Q2 2022, an estimated $63K.
Profund Advisors first reported a position in Antares Pharma, Inc. in Q1 2014 and held it in 6 quarters.
Profund Advisors's Antares Pharma, Inc. position peaked at $72K in Q2 2021.
1 fund tracked by Wall St. Rank held Antares Pharma, Inc. as of Q2 2022.

Based on Profund Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.